Lab Members


Rebecca M. LynchRebecca M. Lynch, Ph.D.
Assistant Professor

Rebecca M. Lynch, Ph.D., joined the GW Department of Microbiology, Immunology and Tropical Medicine University in February 2016 as an Assistant Professor.

Dr. Lynch graduated with a B.S. in Molecular, Cellular and Developmental Biology from Yale University in 2003. She worked for two years as a research technician before embarking on a PhD in Immunology and Molecular Pathogenesis 
at Emory University under supervision of Dr. Cynthia Derdeyn. During her graduate studies, Dr. Lynch characterized the role of the HIV envelope in the escape from neutralizing antibodies during HIV subtype C infection, and received two Young Investigator awards and three NIH/NIAID scholarships. Following her graduation in 2010, Dr. Lynch performed postdoctoral studies investigating the properties and origins of broadly neutralizing HIV antibodies at the Vaccine Research Center directed by Dr. John Mascola at the National Institutes of Health (NIH). Dr. Lynch has published over 20 research articles to date and is the holder of a K22 career transition award.


Julia ReczekJulia Reczek



Michelle PapaMichelle Papa


Anjali BhatnagerAnjali Bhatnager


Leyn ShakhtourLeyn Shakhtour


Andrew WilsonAndrew Wilson


Adam WardAdam Ward

Adam Ward graduated with a B.Sc. in Environmental Sciences (2011) and an M.Sc. in Comparative Biomedical Sciences (2015) from North Carolina State University. Adam also completed George Washington University's Graduate Certificate program in LGBT Health Policy & Practice (2015) before joining the Ph.D. program in Epidemiology in the Milken Institute School of Public Health at GWU. Adam works as a Research Assistant and is a Ph.D. candidate in the laboratory of R. Brad Jones, Ph.D., in the Department of Microbiology, Immunology, and Tropical Medicine within the School of Medicine and Health Sciences at GWU, and in the Division of Infectious Diseases at Weill Cornell Medicine in New York City. His research focuses broadly on HIV cure and eradication strategies. His current research includes a cross-sectional observational study on clinical, demographic, and behavioral factors associated with HIV reservoir size; a longitudinal observational study on HIV-specific T-cell responses, HIV persistence, and inflammation in the ACTG A5321 cohort; developing a novel humanized mouse model to study latency reversal from natural patient-derived HIV reservoirs; study of the central nervous system HIV reservoir and implications for cure strategies; investigating immunotherapeutics in animal and cell culture models, and molecular epidemiology studies. In addition to his research experience, Adam has extensive experience in community outreach and engagement and a passion for public health.